R&D Parental permission, child assent, and adolescent autonomy i... As a vulnerable population, children in general must rely on their parents or guardians to provide informed consent for them to participate in research.
News Gilead's twice-yearly PrEP drug is cleared by FDA Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face